Detailed View
RVMD - Revolution Medicines, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
30,645,778,432
Adj EBIT (TTM)
-1,386,831,000
Enterprise Value
28,737,694,432
Last Price
144.15
Earnings Yield
-4.83%
Return on Capital
-73.23%
Capital
1,893,730,000
1Y Price Chart
Last Price: $144.15
1Y Change: 256.63%
As of 2026-05-11 | 1Y Change: 256.63%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 0 | -445,222,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -361,626,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -315,269,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -264,714,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -240,760,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -216,310,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -175,712,000 |
| 2024-06-30 | 10-Q | 2024 | 0 | -156,643,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.